How did UNBSF's recent EPS compare to expectations?
The most recent EPS for Uni-Bio Science Group Ltd is $, expectations of $.
How did Uni-Bio Science Group Ltd UNBSF's revenue perform in the last quarter?
Uni-Bio Science Group Ltd revenue for the last quarter is $
What is the revenue estimate for Uni-Bio Science Group Ltd?
According to of Wall street analyst, the revenue estimate of Uni-Bio Science Group Ltd range from $ to $
What's the earning quality score for Uni-Bio Science Group Ltd?
Uni-Bio Science Group Ltd has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Uni-Bio Science Group Ltd report earnings?
Uni-Bio Science Group Ltd next earnings report is expected in 2024-11-26
What are Uni-Bio Science Group Ltd's expected earnings?
Uni-Bio Science Group Ltd expected earnings is $, according to wall-street analysts.
Did Uni-Bio Science Group Ltd beat earnings expectations?
Uni-Bio Science Group Ltd recent earnings of $ expectations.
Key Stats
Prev.Close
$0.004
Open
--
Day's Range
-
52 week range
$0.004 - $0.004
Volume
--
Avg.Volume
0
Dividend yield
--
EPS (TTM)
0.00
Market Cap
$23.8M
What is UNBSF?
Uni-Bio Science Group Ltd. is an investment holding company with interests in pharmaceutical research and development. The company employs 504 full-time employees The company went IPO on 2001-11-12. The firm operates its business through three segments. Biological Pharmaceutical Products segment is mainly engaged in the manufacture and sale of biological pharmaceutical products. Chemical Pharmaceutical Products segment is mainly engaged in the manufacture and sale of chemical pharmaceutical products. Pipeline Products segment is mainly engaged in the research and development of pharmaceutical products.